-
Kelun-Biotech's New Drug Application for Its Novel Next-generation Selective RET Inhibitor A400/EP0031 Accepted for Review by the NMPA for the Treatment of RET-fusion positive NSCLC
23 Sep 2025 04:55 GMT
… U.K.-based international oncology drug development company, an exclusive license to develop …
-
K-bio’s 'Power of Platform': 10 Trillion Won in Technology Exports This Year Alone
22 Sep 2025 19:10 GMT
… a U.S.-based new drug development company.
As the demand for biopharmaceuticals … . Among the top 10 new drug development companies by KOSDAQ market capitalization, all …
-
Drug development company Inotiv reports ransomware attack to SEC
19 Aug 2025 13:28 GMT
An Indiana-based drug research company said a recent ransomware attack has disrupted its business operations and forced a shutdown of critical systems.
Inotiv told regulators at the Securities Exchange Commission that the cybersecurity incident was …
-
AI robotic drug development company Persist AI raises $12 million
22 May 2025 03:46 GMT
-
Algernon Announces Preferred Share Class Approved at Annual and Special Meeting
19 Sep 2025 20:39 GMT
… , a private U.S. based drug development company advancing a chronic cough drug …
-
Drug development company lands £1.1m boost marking “significant milestone”
11 Apr 2025 11:11 GMT
A Newcastle-based drug development company has secured a £1.1m …
-
AI Drug Development Company Receives $600M in First Round Financing
02 Apr 2025 16:10 GMT
Isomorphic Labs, an AI-first drug design and development company, announced it has raised $600 Million in its first external funding round. The financing round is led by Thrive Capital, with participation from GV, and follow-on capital from existing …
-
LabConnect Appoints Bill Finger as Senior Vice President, Global Strategic Services
18 Sep 2025 19:41 GMT
… specialized testing expertise means that drug development companies can rely on one provider …
-
EXCL: DHSC-owned drug development company to close
06 Mar 2025 23:46 GMT
Porton Biopharma, a drug development and production company owned by the Department of Health and Social Care, will be shut down, CSW can reveal.
The firm was part of Public Health England (the predecessor to the UK Health Security Agency) until 2015, …
-
Biovance Capital leads Series A Financing in Mondego Bio together with OrbiMed and Torrey Pines
18 Sep 2025 08:59 GMT
… fund invests in early-stage drug development companies across Europe, with a special …